Experts call new smart insulins the “Holy Grail” of diabetes care. NEW YORK, Aug 13: Scientists have made significant strides in diabetes treatment with the development of glucose-responsive “smart” insulins. These innovative insulins are designed to activate only when blood sugar levels are elevated and deactivate when levels return to normal, potentially transforming the management …